Exploring the Heterogeneity of Pediatric Neuroendocrine Tumors: Single-Center Experience
Hormone Research in Paediatrics · 2025
DOI: 10.1159/000546507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2025. Verfasst von Cansu Koc und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, drcansukoc@gmail.com. Hauptthemen laut MEDLINE: Neuroendocrine Tumors.
Abstract (Originalsprache)
Introduction
Neuroendocrine tumors (NETs) are rare, slow-growing tumors with distinct clinical manifestations that can be challenging to diagnose and treat, particularly in children. This retrospective study aimed to improve diagnosis and treatment of NETs by evaluating their clinical course, hormonal activity, and long-term effects in children.
Methods
A retrospective study was conducted on 26 pediatric patients diagnosed with NETs between 2000 and 2024. The cohort included patients with pheochromocytoma and paraganglioma (PPGL), gastroenteropancreatic neuroendocrine tumors (GEP-NETs) medullary thyroid carcinoma (MTC), C cell hyperplasia. The data included demographic, clinical, laboratory, and imaging results.
Results
The study cohort included 26 patients (57.6% male). The median age for diagnosis of NETs was 8.8 (range: 1.0–16.6) years. Among the NETs, 15.4% were GEP-NETs, 15.4% were PPGL, 15.4% were C cell hyperplasia and 53.8% were MTC. The median follow-up was 5 (range: 1–14) years. Among the patients in the study cohort, only one patient died due to MTC. Genetic analysis revealed mutations in the RET gene in 69.2% of patients, mutations in the VHL gene in 3.8%, and no mutations in 3.8%. 23% of the patients did not undergo genetic testing.
Conclusion
Early diagnosis, genetic screening, and long-term follow-up are crucial in managing pediatric NETs to reduce morbidity and mortality. Genetic testing is essential for identifying comorbidities and screening family members at risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, drcansukoc@gmail.com.
- Department of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
- Department of Child Health and Diseases, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
- Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
- Department of Pediatric Surgery, Istanbul University, Istanbul, Turkey.
- Department of General Surgery Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Zitieren
APA
Koc, C., Yola Atalah, Y. E., Bayrakoglu, S., Yildiz, M., Onder, S., Yegen, G., Erginel, B., Aksakal, N., Giles, Y., Kardelen, A. D., Poyrazoglu, S., Bas, F., & Darendeliler, F. (2025). Exploring the Heterogeneity of Pediatric Neuroendocrine Tumors: Single-Center Experience. Hormone Research in Paediatrics. https://doi.org/10.1159/000546507
Vancouver
Koc C, Yola Atalah YE, Bayrakoglu S, Yildiz M, Onder S, Yegen G, et al. Exploring the Heterogeneity of Pediatric Neuroendocrine Tumors: Single-Center Experience. Hormone Research in Paediatrics. 2025. doi:10.1159/000546507
BibTeX
@article{Koc2025,
author = {Koc, Cansu and Yola Atalah, Yaprak Ece and Bayrakoglu, Sedat and Yildiz, Melek and Onder, Semen and Yegen, Gulcin and Erginel, Basak and Aksakal, Nihat and Giles, Yasemin and Kardelen, Asli Derya and Poyrazoglu, Sukran and Bas, Firdevs and Darendeliler, Feyza},
title = {Exploring the Heterogeneity of Pediatric Neuroendocrine Tumors: Single-Center Experience},
journal = {Hormone Research in Paediatrics},
year = {2025},
doi = {10.1159/000546507}
}
EUVIMED